After phosphorylation to the corresponding diphosphates, 2'-azido-2'-deoxycytidine and 2'-difluorocytidine act as powerful inhibitors of ribonudeotide reductase.
Transcription of the single-stranded RNA of the human immunodeficiency virus type 1 (HIV-1) into double-stranded DNA is important for the maintenance of viral infection (1) . This process involves the polymerization of the four deoxyribonucleoside triphosphates (dNTPs) by the viral reverse transcriptase. Certain deoxynucleotide analogs inhibit this reaction rather specifically, and among them the 5'-triphosphate of 3'-deoxy-3'-azidothymidine (AzTTP) has found clinical application (2) . The analog is administered as the nonphosphorylated nucleoside and, to become an inhibitor of the reverse transcriptase, must be phosphorylated by the cellular kinases normally involved in the phosphorylation of thymidine and thymidine phosphates (3) . In cultured human CEM lymphoblasts, the phosphorylation of AzT was increased considerably by low concentrations of hydroxyurea, a known inhibitor of the enzyme ribonucleotide reductase (4) . This host enzyme provides the dNTPs required for both host and viral DNA synthesis. The mechanism for the accelerated phosphorylation of AzT was not clarified, but it was suggested that the observed effect might be of clinical interest for combination therapy of HIV infection with AzT and hydroxyurea.
Interest in the potential use of hydroxyurea in AIDS therapy obtained a renewed impetus from the recent work of Gao et al. (5) . From studies of viral DNA replication in infected resting lymphocytes, these authors concluded that the activity of the reverse transcriptase critically depends on dNTP pool sizes. Indeed, resting lymphocytes harbor a pool of incomplete HIV DNA possibly of importance for HIV-1 pathogenesis (6) . In stimulated lymphocytes suboptimal dNTP concentrations, induced by inhibition of ribonucleotide reductase with hydroxyurea, reduced the processivity of reverse transcriptase and produced incomplete DNA molecules (5). Thus, it was suggested that low doses of hydroxyurea, alone or in combination with nucleotide analogs, could be employed in clinical trials. Also other recent work (7) suggests that inhibition of dNTP synthesis per se might be of benefit in AIDS therapy. In this context it seemed likely that the diphosphates of various 2'-substituted deoxycytidine analogs might have a theoretical advantage over hydroxyurea as inhibitors of ribonucleotide reductase. The phosphorylation of the nucleoside analog depends on the activity of deoxycytidine kinase, an enzyme highly expressed in lymphoid cells (8) . Therefore, inhibition of the reductase should mainly occur in such cells. Here we compare the effects of two such analogs, 2'-deoxy-2'-azidocytidine (AzC) and 2'-deoxy-2'-difluorocytidine (F2C), with that of hydroxyurea on the phosphorylation of AzT in cultured CEM cells. All nucleotide were calculated from the total radioactivity in the relevant fractions.
In some experiments the medium after removal of cells by centrifugation was deproteinized (11) and analyzed by HPLC. To separate AzT from.,thymine, an aliquot of deproteinized medium was separated by HPLC as described above by using 20% methanol in water as eluent. Thymine appeared between 4.5 and 6 min, and AzT appeared between 16 and 18 min. To separate AzT from AzT phosphates, a portion of the medium was added to a 1-ml column of Dowex-l-Cl-, and AzT was removed by 10 ml of 25 mM KC1. AzT phosphates were subsequently recovered from the column by elution with 3 ml of 0.3 M HCI/25 mM KCl and quantitated from the radioactivity in this fiaction.
Flow Cyteri Analyses. Cells (1 x 106) were centrifuged, washed and fixed with 2 ml ofcold 70% ethanol, and stored at 4eC until processing (2-4 days). Fixed cells were washed with phosphate-buffered saline and then stained at 3TC for 30 min with 0.12% sodium citrate containing 0.05 mg of propidium iodide (Sigma) and 1 mg ofpancreatic ribonuclease (Sigma) per ml. After overnight incubation in the dark at 40C, flowcytometric analysis of DNA (12) The inhibitors were added 24 h after seeding. After an additional 12 h, [3H]AzT (either 0.1 or 1 pM) was added and incubation was continued for5 h. At the end ofthis time period, the amount ofintracellular AzT nucleotides was determined, and cells from parallel cultures (without AzT) were counted to determine the inhibition of growth. ND, not determined. h after drug addition tase inhibitors for 12 or 24 h. To assess the effect of pretreatment more closely, we determined AzT phosphorylation at various time points in cells pretreated with the inhibitors from 3 to 36 h. We also determined the effect of the drugs on cell growth and progression through the cell cycle. During the first 14 h after addition of the three drugs, cell replication was almost completely blocked, as shown by the growth curves in Fig. 1 Fig. 2A) , suggesting that drug treatment had severely diminished the recruitment of cells from S phase without affecting the exit from G2/M. Already at this time the number of cells in early S phase was slightly increased, and this increase became still more apparent at later time points (Fig. 2B) . From the DNA fluorescence patterns (Fig. 2C) , it is apparent that the distribution of cells within the S phase changed with time in the drug-treated cultures. At first, early S-phase cells dominated and later were replaced by cells in middle and late S phase, indicating a slower progression through S phase. Note that in the F2C-treated cultures, the delay in S phase lasted for a shorter time period and that the DNA pattern after 38 h had reverted to that of the control.
AzT phosphorylation (Fig. 3 ) was stimulated to some extent at all time points by the drugs, but the magnitude ofthe effect was time dependent. Between 3 and 5 h, AzT phosphorylation was on the average augmented only 1.2-fold, whereas after 12-14 h the stimulation was 2.6-fold. With AzC and hydroxyurea the stimulation remained high to the end of the experiment, whereas the effect of F2C declined rapidly. A comparison of these results with the cell cycle data (Fig. 2) correlates the increase in phosphorylation with the effects of the drugs on the cell cycle. AzC and hydroxyurea maintained their effect to the very end of the experiment, with a large portion of the cells in S phase, whereas the effect of F2C was more short-lived and disappeared after 38 h.
Accumulation of AzT Nudeoides During Drug Treatment. To determine the extent of AzT AzT was added to untreated control cultures and to cultures pretreated with the three drugs for 10 h. Parallel samples were removed at time intervals between 3 and 33 h after AzT addition and analyzed for AzT phosphorylation (Fig. 4A ) and for cell cycle distribution (Fig. 4B) .
In the control cultures, AzT nucleotides increased slowly by 50% between 3 and 12 h, but then declined to 30% of the original value after 33 h. Hydroxyurea, AzC, and F2C had all increased AzT phosphorylation 3-to 4-fold after 3 h. Thereafter the effects of the three drugs ran different time courses. In the hydroxyurea-and AzC-treated cultures, the amount of AzT nucleotides showed an increase of about 50%c between 3 and 12 h, which was then followed by a decrease. Note, however, that the decrease occurred later with AzC. Compared with the controls, AzT phosphorylation was 3 to 4 times greater at all time points. The stimulation by F2C was already maximal after 3 h and then decreased continuously, with the 26-and 33-h values not differing from the corresponding control values.
A comparison of these results with the cell cycle analyses (Fig. 4B) is illuminating. In the control cultures, approximately 30% of the cells were in S phase at all times. In the cultures pretreated with drugs, twice as many cells were already in S phase at the first time point, 3 h after addition of AzT (but 13 h after drug addition). In the AzC-treated cultures, this value remained constant at all times; also the hydroxyurea-treated cells maintained a large percentage of cells in S phase, even though there was a clear decline after 33 h. The situation was different with F2C: between 3 and 12 h, the number of S-phase cells decreased from 68% to 50%o
and after 26 h did not differ from the control.
The DNA fluorescence pattern in this experiment was similar to results shown in Fig. 2C (data not shown) (9, 16) . Also F2C inhibits ribonucleotide reductase (17) but is, in addition, incorporated into DNA (18) , and this gives an essentially irreversible inhibition of chain elongation. At the low concentrations of the analog used in the present experiments, inhibition was reversible and therefore probably due to an effect of the drug on the reductase.
Our flow cytometric DNA analyses demonstrate that the three drugs delayed the passage of cells through the S phase of the cell cycle. This is indicated by the large drop in the percentage of cells in the G2 and M phases at early times after addition of drugs ( Fig. 2A) . Thereafter, cells accumulated in late G1 and early S phases and finally shifted progressively to middle and late S phase (Fig. 2 B and C) . It was shown earlier that hydroxyurea can block the cell cycle at the G1/S boundary and be used to synchronize cultured cells (19) . In our experiments the inhibition of DNA synthesis was incomplete and resulted in a slowdown of strand elongation, with A partial synchronization, and gradual accumulation ofthe cells in S phase.
The increase in phosphorylation of AzT closely followed the changes in the frequency distribution. This does by itself not prove a causal relationship but strongly suggests one. Phosphorylation of AzT is mainly catalyzed by the cytoplasmatic thymidine kinase (20) , a cell cycle-regulated enzyme with highest activity in late G1 and S phases. Therefore, one can expect that an accumulation of cells in these growth phases will increase the activity of the enzyme in the cell population and the phosphorylation of AzT.
At the chosen concentration of the inhibitors, each had the same effect during the first 14 h. After that time the effects of F2C declined rapidly, compared with those of hydroxyurea and AzC. This might be explained by degradation of F2C nucleotides by dCMP deaminase (21) . The "normalization" of the cell cycle (Fig. 2C) and the drop in AzT phosphorylation (Fig. 3) were parallel phenomena, strengthening our concept that the increased phosphorylation of AzT is caused by the effect of the drug on the cell cycle.
In connection with AIDS therapy, our results have two main implications. The first concerns the possibility to achieve a more selective effect in lymphoid cells by choosing deoxycytidine analogs as inhibitors of ribonucleotide reductase rather than hydroxyurea. The second implication is that the use ofany inhibitor ofthe reductase will interfere with the normal passage ofcells through the cell cycle. This effect will potentiate the activity of AzT and other thymidine analogs, ifthey are combined with the reductase inhibitors. In addition to the direct inhibition of reverse transcriptase they will, however, also interfere with cell replication. By using a low dosage of deoxycytidine analogs, it might be possible to minimize the toxic effects and limit them to the lymphoid system. On balance, it does not seem unreasonable to test such an approach in an appropriate animal system.
